[ Stock Screener ] These 6 Tickers are looking Strong

This is a must read. If you cannot see this email properly, please click [here]( [61fa9913e01c...] --------------------------------------------------------------- [707% Growth For American Lithium Company After They Fight Back Against China]( [They've Already Seen 707% Growth In 2021, And That Could Just Be The Start]([aff_i?offer_...] --------------------------------------------------------------- Dear Reader, We just ran our screens and wanted to point out 6 'Strong Buy' Stocks that you might want to keep an eye on....Keep in mind, these are very volatile stocks so please do your own research before you make any investments. We are not recommending these stocks. See the list below. --------------------------------------------------------------- [The U.S. Solution to China's Copper Grab]( [5439d433-d80...](China consumes 54% of the world's copper. Yet China mines only 8% of its copper needs, while plundering Africa, Latin America and South America for copper. The U.S. is left scrambling for new copper sources. But there's a North American copper sweet spot overlooked by China – for now. [Find Out Where This Copper Hotspot Is and How You Can Benefit]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Karuna Therapeutics, KRTX]( - Buy to Strong Buy [TipRanks.com]( also reports that [Karuna Therapeutics]( currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $181.17. The target pricing ranges from a high forecast of $190.00 down to a low forecast of $160.00. [Karuna Therapeutics (KRTX)](’s last closing price was $131.37 which would put the average price target at 37.91% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Weak buy rating. [Click for chart >>]( ----------------------------------------------------- [Privia Health Group, PRVA]( - Buy to Strong Buy [TipRanks.com]( also reports that [Privia Health Group]( currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $34.43. The target pricing ranges from a high forecast of $40.00 down to a low forecast of $27.00. [Privia Health Group (PRVA)](’s last closing price was $33.29 which would put the average price target at 3.42% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>]( ----------------------------------------------------- --------------------------------------------------------------- [Secure Your Financial Future]( Last time this happened was 21 years ago, and more than $10 trillion in wealth surged through the hands of investors. [Shocking details here.](//trailer.web-view.net/Links/0X142A5F93F590B1F70C8C146D65F5C2F151B8CB1CDA18AEE5CD64BEF13C9BF746FDFD12DE365CA06F9A0EC4C3E95FC2E3013175994F42ED1FD5204FCFBC5BDF4F58817A62CDD4649F.htm [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Instructure Holdings, INST]( - Buy to Strong Buy [TipRanks.com]( also reports that [Instructure Holdings]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $28.20. The target pricing ranges from a high forecast of $34.00 down to a low forecast of $20.00. [Instructure Holdings (INST)](’s last closing price was $23.21 which would put the average price target at 21.50% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Weak buy rating. [Click for chart >>]( ----------------------------------------------------- [Harmony Biosciences Holdings, HRMY]( - Buy to Strong Buy [TipRanks.com]( also reports that [Harmony Biosciences Holdings]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $59.75. The target pricing ranges from a high forecast of $63.00 down to a low forecast of $57.00. [Harmony Biosciences Holdings (HRMY)](’s last closing price was $54.65 which would put the average price target at 9.33% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bearish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>]( ----------------------------------------------------- --------------------------------------------------------------- [Four Penny Stocks to Target for A Rockstar Portfolio In 2022]( [5af39064-66d...](Turn on Fox Business News on Wednesday mornings, and you’ve likely seen Shah Gilani – but you’ve never heard him talk about this. You hear about the Amazons, the Apples, the Microsofts - but he’s making the claim that they won’t allow him to talk about a tiny corner of the market producing significant returns for retail investors. [See why right here.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Verra Mobility, VRRM]( - Buy to Strong Buy [TipRanks.com]( also reports that [Verra Mobility]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $18.75. The target pricing ranges from a high forecast of $21.00 down to a low forecast of $16.00. [Verra Mobility (VRRM)](’s last closing price was $15.68 which would put the average price target at 19.58% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a buy rating. [Click for chart >>]( ----------------------------------------------------- [Lamb Weston Holdings, LW]( - Buy to Strong Buy [TipRanks.com]( also reports that [Lamb Weston Holdings]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $80.60. The target pricing ranges from a high forecast of $85.00 down to a low forecast of $77.00. [Lamb Weston Holdings (LW)](’s last closing price was $72.97 which would put the average price target at 10.46% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>]( ----------------------------------------------------- Pricing & Percentages as of approximately 10:00am EST. [TipRanks.com]( tracks and measures the performance of over 50,000 financial experts. The TipRanks Star Ranking TM is calculated based on expert success rate, average return and statistical significance. [Get more from TipRanks.com here >>]( --------------------------------------------------------------- [Copper More Critical than Lithium?]( [be7e813c-17c...](Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found. [See How You Can Benefit From New Copper Discoveries.](//trailer.web-view.net/Links/0XF2BFEA46C10CC51129491EF1BFDE4C231F29496F980BDB75A0C92E85D07F8614D20DB101A5F731D89A0EC4C3E95FC2E3013175994F42ED1FD5204FCFBC5BDF4F58817A62CDD4649F.htm [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- Newsletter Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. Sandpiper Marketing Group, LLC | PO Box 407 | Mount Mourne | North Carolina | 28123 | United States | 8458030954 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software